2026 ADA Gestational Diabetes Guidelines Explained Simply

Your doctor mentions "ADA guidelines" or "standard of care" for gestational diabetes, but what does that actually mean? The American Diabetes Association (ADA) publishes recommendations that guide how GD is diagnosed and managed. Understanding these guidelines helps you participate actively in your care.

This guide explains the 2026 ADA guidelines for gestational diabetes in plain language - no medical jargon, just practical information about what the latest recommendations mean for you.

Understanding the guidelines is the first step. Our free meal planner helps you follow dietary recommendations that align with ADA guidance.

What Are the ADA Guidelines?

About the American Diabetes Association

The ADA is the leading organization for diabetes research, education, and advocacy in the United States. Each year, they publish Standards of Care - evidence-based recommendations that guide healthcare providers in managing all types of diabetes, including gestational diabetes.

Why These Guidelines Matter

• Evidence-based: Recommendations come from the best available research
• Standardized care: Help ensure consistent treatment across providers
• Updated annually: Incorporate new research findings
• Widely followed: Most US healthcare providers use these as their foundation

Guidelines vs. Your Individual Care

Important note: Guidelines are recommendations, not rigid rules. Your healthcare provider may adjust recommendations based on:

• Your individual health history
• How your body responds to treatment
• Your preferences and circumstances
• Other conditions you may have
• Current research and clinical experience

If your care differs slightly from general guidelines, ask your provider to explain why. There may be good reasons for individualized approaches.

Diagnosis: How GD Is Identified

When to Screen

The ADA recommends screening for gestational diabetes at 24-28 weeks of pregnancy for women not previously diagnosed with diabetes.

Earlier testing (at first prenatal visit) is recommended for women with risk factors:

• Overweight or obesity
• Family history of type 2 diabetes
• Previous GD in earlier pregnancy
• Previous delivery of baby weighing 9+ lbs
• Polycystic ovary syndrome (PCOS)
• High-risk ethnic background
• Signs of insulin resistance

Screening Methods

The ADA recognizes two acceptable approaches:

Two-Step Method (Most Common in US):

1. Step 1: 50g Glucose Screen
   • Drink glucose solution (no fasting required)
   • Blood drawn at 1 hour
   • If result is 140+ mg/dL (or 130+ by some criteria), proceed to step 2
2. Step 2: 100g Glucose Tolerance Test (GTT)
   • Fasting required (8+ hours)
   • Blood drawn fasting, then at 1, 2, and 3 hours after drinking glucose
   • GD diagnosed if 2+ values meet or exceed thresholds

One-Step Method (International Standard):

• 75g glucose tolerance test
• Fasting required
• Blood drawn fasting, at 1 hour, and at 2 hours
• GD diagnosed if any ONE value meets threshold

Both methods are valid. The one-step method identifies more women with GD but treats milder cases. Your provider or institution will use one approach consistently.

Blood Sugar Targets

The 2026 ADA Recommendations

Self-monitoring blood glucose targets for gestational diabetes:

• Fasting: Below 95 mg/dL (5.3 mmol/L)
• 1 hour post-meal: Below 140 mg/dL (7.8 mmol/L)
• 2 hours post-meal: Below 120 mg/dL (6.7 mmol/L)

Understanding the Targets

Why these specific numbers?

Research shows that keeping blood sugar within these ranges significantly reduces risks associated with GD - including larger babies, delivery complications, and neonatal hypoglycemia. The targets balance safety with achievability.

Post-meal timing

The ADA notes that post-meal testing can be done at either 1 or 2 hours. Timing should start when you begin eating, and you should be consistent with whichever timing your provider recommends.

"Below" vs. "at or below"

The targets say "below," meaning hitting exactly 95 fasting or 140 at 1-hour is technically at target. A reading of 94 or 139 is clearly in range.

When Targets Might Be Adjusted

Your provider might modify targets if:

• You're experiencing frequent low blood sugar
• You have other health conditions affecting recommendations
• Baby is growing appropriately despite slightly elevated readings
• Very tight control is causing excessive stress or eating problems

Treatment Approach

First Line: Lifestyle Modification

The ADA recommends starting with lifestyle changes:

Medical Nutrition Therapy (MNT)

• Consultation with registered dietitian recommended
• Individualized meal plan
• Focus on carbohydrate distribution and quality
• Three meals and 2-3 snacks typically recommended
• Emphasis on complex carbohydrates with fiber

Physical Activity

• Moderate exercise recommended if no contraindications
• Walking after meals can help lower blood sugar
• Goal: 30 minutes most days
• Always clear exercise plans with your provider

When Medication Is Needed

The ADA recommends adding medication when blood glucose targets are not met with lifestyle changes alone. Typically this means:

• Consistently elevated readings despite following dietary recommendations
• Usually assessed after 1-2 weeks of lifestyle modifications
• High fasting numbers often require medication sooner (less responsive to diet)

Medication Options

Insulin (First Choice):

• Does not cross the placenta
• Long track record of safety in pregnancy
• Allows precise dose adjustment
• May use long-acting, short-acting, or both depending on patterns

Metformin:

• Oral medication, easier than injections
• Does cross the placenta
• Limited long-term data in pregnancy
• Some providers use as alternative when patient declines insulin
• ADA notes that insulin is preferred but metformin may be considered

Glyburide:

• Previously used more commonly
• Research now suggests higher failure rate than insulin or metformin
• ADA generally recommends against as first choice

Managing GD through diet is the first step. Our free meal planner helps you create meal plans that support your blood sugar goals.

Monitoring During Pregnancy

Blood Sugar Monitoring

ADA recommendations for self-monitoring:

• Daily self-monitoring of blood glucose
• Fasting and post-meal readings
• Frequency may vary based on control and treatment
• Results guide treatment adjustments

Fetal Monitoring

The ADA recommends appropriate fetal surveillance in GD pregnancies. What this looks like varies by provider but may include:

• Growth ultrasounds to assess baby's size
• Non-stress tests (NSTs) in third trimester
• More frequent monitoring if on medication or with complications

A1C Testing

A1C (average blood sugar over 2-3 months) may be checked but is less useful in pregnancy because:

• GD develops mid-pregnancy, so prior months aren't relevant
• Pregnancy affects red blood cell turnover, making A1C less accurate
• Daily glucose monitoring provides more useful information

Delivery Considerations

Timing of Delivery

ADA guidance on delivery timing:

• Well-controlled GD (diet-managed): May await spontaneous labor up to 40-41 weeks
• Medication-controlled GD: Delivery by 39 weeks often recommended
• Poorly controlled or complications: Earlier delivery may be considered

Your specific timing will be determined by your healthcare team based on your individual situation.

Mode of Delivery

GD alone doesn't require cesarean delivery. Vaginal delivery is appropriate unless there are other indications. Cesarean may be recommended if baby is estimated to be very large (macrosomia).

After Delivery

Immediate Postpartum

• Blood sugar monitoring typically continues briefly after delivery
• Most women can stop diabetes medications immediately
• Blood sugar usually normalizes rapidly as pregnancy hormones drop
• Baby may need blood sugar monitoring for first 24 hours

Postpartum Testing

The ADA strongly recommends postpartum diabetes screening:

• When: 4-12 weeks after delivery
• Test: 75g glucose tolerance test (not A1C alone)
• Why: To check if diabetes has resolved or if type 2 diabetes is present

This test is important but often skipped. About 50% of women with GD develop type 2 diabetes within 10 years without intervention.

Long-Term Follow-Up

For women with history of GD, the ADA recommends:

• Lifelong screening for diabetes at least every 3 years
• Earlier screening if planning another pregnancy
• Lifestyle modifications to reduce type 2 diabetes risk
• Attention to cardiovascular risk factors

What the Guidelines Mean for You

Key Takeaways

• Screening is important: Accept GD screening at 24-28 weeks
• Targets are achievable: Most women can reach targets with diet and exercise
• Medication isn't failure: If needed, it's the appropriate next step
• Monitoring matters: Track your numbers to guide treatment
• Follow-up is crucial: Don't skip postpartum testing

Questions to Ask Your Provider

• What blood sugar targets should I aim for?
• Should I test at 1 hour or 2 hours after meals?
• When would you recommend starting medication?
• How often will we monitor the baby?
• What's the plan for delivery timing?
• When should I have postpartum testing?

Beyond the Guidelines

Remember that guidelines are a starting point, not a rigid rulebook. The best care combines evidence-based recommendations with your individual needs, preferences, and circumstances.

Stay informed, ask questions, and work with your healthcare team. You're an active participant in your care, not just a passive recipient of treatment.

Ready to put dietary guidelines into practice? Our free GD meal planner creates personalized plans aligned with current recommendations.

Related resources:

• 7-Day GD Meal Plan - Put ADA dietary guidance into practice
• Blood Sugar Monitoring Guide - Master your daily testing
• Metformin for GD - Complete medication guide